PFBT
MRNA icon

Parkside Financial Bank & Trust’s Moderna MRNA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Sell
1,774
-33
-2% -$1.71K 0.01% 658
2026
Q1 		$91.8K Buy
1,807
+282
+18% +$13.2K 0.01% 719
2025
Q4 		$45K Sell
1,525
-962
-39% -$26.1K ﹤0.01% 1002
2025
Q3 		$64.2K Buy
2,487
+140
+6% +$3.9K 0.01% 843
2025
Q2 		$64.8K Buy
2,347
+375
+19% +$9.88K 0.01% 807
2025
Q1 		$55.9K Buy
1,972
+100
+5% +$3.55K 0.01% 792
2024
Q4 		$77.8K Buy
1,872
+624
+50% +$29.8K 0.01% 665
2024
Q3 		$83.4K Sell
1,248
-165
-12% -$15.1K 0.01% 606
2024
Q2 		$168K Buy
1,413
+260
+23% +$32.9K 0.03% 389
2024
Q1 		$123K Buy
1,153
+595
+107% +$60K 0.02% 468
2023
Q4 		$55.5K Sell
558
-7
-1% -$589 0.01% 652
2023
Q3 		$58.4K Buy
565
+175
+45% +$19.5K 0.01% 572
2023
Q2 		$47.4K Sell
390
-59
-13% -$7.87K 0.01% 635
2023
Q1 		$69K Buy
449
+1
+0.2% +$165 0.02% 484
2022
Q4 		$80.5K Buy
448
+207
+86% +$33.8K 0.02% 435
2022
Q3 		$29K Sell
241
-130
-35% -$19.7K 0.01% 688
2022
Q2 		$53K Buy
371
+62
+20% +$8.86K 0.02% 504
2022
Q1 		$53K Buy
309
+196
+173% +$33K 0.01% 529
2021
Q4 		$29K Sell
113
-152
-57% -$44.4K 0.01% 691
2021
Q3 		$102K Buy
265
+214
+420% +$78.9K 0.03% 322
2021
Q2 		$12K Sell
51
-42
-45% -$7.51K ﹤0.01% 914
2021
Q1 		$12K Sell
93
-2
-2% -$290 ﹤0.01% 882
2020
Q4 		$10K Buy
95
+8
+9% +$809 ﹤0.01% 886
2020
Q3 		$6K Buy
87
+60
+222% +$4.18K ﹤0.01% 895
2020
Q2 		$2K Buy
+27
New +$1.48K ﹤0.01% 1182

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Parkside Financial Bank & Trust's MRNA Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Moderna (MRNA) stake by 1.8% in Q2 2026, selling an estimated $1.71K and leaving 1,774 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #658.

Parkside Financial Bank & Trust first reported a position in MRNA in Q2 2020 and has held it in 25 quarters since. The position peaked at $168K in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Parkside Financial Bank & Trust held 1,774 shares of Moderna worth $124K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 33 Moderna shares in Q2 2026, an estimated $1.71K.
  • Moderna made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #658 holding.
  • Parkside Financial Bank & Trust first reported a position in Moderna in Q2 2020 and has held it in 25 quarters since.
  • Parkside Financial Bank & Trust's Moderna position peaked at $168K in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.